Home >> Marketplace Directory >> ACD, Hopkins reach cancer biomarkers deal, 4/13:84

ACD, Hopkins reach cancer biomarkers deal, 4/13:84

image_pdfCreate PDF

RNAscope is an automated multiplex RNA in situ hybridization platform that detects and quantifies biomarkers with single-molecule sensitivity. The platform provides single-cell gene-expression information within the context of intact tissue, enabling molecular and histopathological analysis on a platform compatible with routine clinical specimens and standard clinical laboratory workflow. RNAscope assays can be developed and validated in two weeks for virtually any gene in any genome. ACD offers RNAscope-based products and services worldwide to scientists in a range of areas, from basic research to companion diagnostics for personalized medicine.

Advanced Cell Diagnostics, 510-576-8800

CAP TODAY
X